Lipoprotein(a) / Jaimini Cegla.

Format:

Video

Author/Creator:

Cegla, Jaimini, author.

Language:

English

Subjects (All):

Cardiovascular system--Diseases.

Cardiovascular system.

Aspirin--therapeutic use.

Aspirin.

Physical Description:

1 streaming video file (19 min., 47 sec.) : color, sound

Other Title:

Lipoprotein

Place of Publication:

London : Henry Stewart Talks Ltd, 2024.

System Details:

video file

Contents:

Introduction

Talk outline: Lp(a) and CV risk

Case study: Mrs K, age 57 (1)

Mrs K: Lp(a) testing

Lp(a) levels are genetically determined

Elevated Lp(a) is a causal risk factor for CVD

Lp(a) is a potent risk factor for MACE

Lp(a) and graded risk

Elevated Lp(a) is a risk factor for CV events across different ethnic groups

Lp(a) pathophysiology

Increased arterial wall inflammation and monocyte activation in patients with elevated Lp(a)

Case study: Mrs K, age 57 (2)

Mrs K.'s risk profile and managing her risk

Talk outline: in whom to measure Lp(a)

International guidelines

In whom to measure Lp(a)

Lp(a) and CAVS

Talk outline: treatment

Treatment options

Aspirin

Reducing residual risk

PCSK9i

Lipoprotein apheresis

Lp(a) targeted therapies in development

Antisense oligonucleotides

Treatment

Manage all risk factors for CVD

Targets

Talk outline: further research

Future work

Thanks for listening!.

Notes:

Description based on publisher supplied metadata and other sources.

Retrieved August 28, 2025, from https://doi.org/10.69645/RYEJ3270.